EGF and breast cancer: In this study, we analyze how FGF1, compared to EGF, affects the survival of the MCF-7 model cell line, extensively applied in breast cancer research [10] and treated with taltobulin, a cytotoxin belonging to the widely used group of drugs that inhibit tubulin polymerization [11].